Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Lift off!!!

<< Previous

Bullboard Posts

Next >>

Comment by Quentin30on Nov 30, 2022 4:37pm

123 Views

Post# 35141067

RE:RE:RE:RE:RE:RE:RE:RE:RE:Lift off!!!

Agreed Buckhenry.... great to see ONCY up, but the market was up anyway, and many stocks were up by this %.

A word of caution is that we've been here before and actually very recently just before the release of the Panc data... and we all watched the price bumped off resistance and drop 25% in days... This latest data will probably be the last potential price catalyst of 2022.

I would be happier if we can bust through $2 by the end of this week, otherwise, I don't see it holding, just every other last news release.

GLTA

<< Previous

Bullboard Posts

Next >>

How to trade on the stock market: A beginner’s guide